Design of an observational multi-country cohort study to assess immunogenicity of multiple vaccine platforms (InVITE)
10Citations signalées
10Institutions associées
6Pays d’affiliation
Résumé fourni par la source
In response to the COVID-19 pandemic, COVID-19 vaccines have been developed, and the World Health Oraganization (WHO) has granted emergency use listing to multiple vaccines. Studies of vaccine immunogenicity data from implementing COVID-19 vaccines by national immunization programs in single studies spanning multiple countries and continents are limited but critically needed to answer public health questions on vaccines, such as comparing immune responses to different vaccines and among different populations.
Institutions
National Institutes of HealthNational Institute of Allergy and Infectious DiseasesFrederick National Laboratory for Cancer ResearchNational Institute of Biomedical ResearchKementerian Kesehatan Republik IndonesiaLiberian Institute for Biomedical ResearchInstituto Nacional de Ciencias Médicas y Nutrición Salvador ZubiránUniversité des Sciences, des Techniques et des Technologies de BamakoInstituto Nacional de Enfermedades RespiratoriasSystex (United States)
Sujets associés
SARS-CoV-2 and COVID-19 ResearchVaccine Coverage and HesitancyCOVID-19 epidemiological studies